about
Determinants of early life immune responses to RSV infectionNeonatal Vaccination: Challenges and Intervention StrategiesInfluenza and respiratory syncytial virus in infants study (IRIS) of hospitalized and non-ill infants aged <1 year in four countries: study design and methodsInfections Caused by HRSV A ON1 Are Predominant among Hospitalized Infants with Bronchiolitis in São Paulo City.Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins.Glucocorticoid Insensitivity in Virally Infected Airway Epithelial Cells Is Dependent on Transforming Growth Factor-β Activity.Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced DiseasesSuppression of IRG-1 Reduces Inflammatory Cell Infiltration and Lung Injury in Respiratory Syncytial Virus Infection by Reducing Production of Reactive Oxygen Species.Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice.Respiratory syncytial virus infection: an innate perspective.Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state.IFNγ Influences Epithelial Anti-viral Responses via Histone Methylation of the Rig-I Promoter.Respiratory syncytial virus vaccines: an update on those in the immediate pipeline.Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.Vaccine development for respiratory syncytial virus.Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.Respiratory syncytial virus infection influences tight junction integrity.Robust Cytokine and Chemokine Response in Nasopharyngeal Secretions: Association With Decreased Severity in Children With Physician Diagnosed Bronchiolitis.Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV reexposure in neonate mice.Respiratory syncytial virus infection in infants with acute leukemia: a retrospective survey of the Japanese Pediatric Leukemia/Lymphoma Study Group.Understanding the ontogeny of the immune system to promote immune-mediated health for life.Respiratory Syncytial Virus (RSV): Targeting the G Protein Provides a New Approach for an Old Problem.Pulmonary Susceptibility of Neonates to Respiratory Syncytial Virus Infection: A Problem of Innate Immunity?Innate Immunity to Respiratory Infection in Early Life.The neonatal anti-viral response fails to control measles virus spread in neurons despite interferon-gamma expression and a Th1-like cytokine profile.Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation.Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus.Neonatal Immunity, Respiratory Virus Infections, and the Development of Asthma.Respiratory syncytial virüs infections in neonates and infantsStaphylococcus aureus colonization and non-influenza respiratory viruses: Interactions and synergism mechanismsA 2-year-old girl with chronic crackles after respiratory syncytial virus infection: a case report
P2860
Q26764790-D2EEC042-B105-4FA8-BC47-E7B8E4C229D0Q28066069-4452428E-5253-4019-9C62-F230CDFF80E7Q29248088-57B1DC11-4C7A-4CC3-92AF-F46D72497057Q33775484-7C00D608-84F2-48DF-BECC-CE8A364B9757Q35995788-95409B8A-E0E6-4353-A1EA-B6210099B06BQ36238505-9332CC32-DB50-46DE-933C-9AC51CF1EAEFQ36246429-C88CF0EA-D345-4EF6-B0CF-65CD9634E7D9Q37174419-17380B3C-CD74-4938-8832-245D6C672649Q37355470-A45A5724-FCF5-4BE3-A957-5FDDAFF289F6Q37577700-82212D6E-461F-4F49-BCEB-F3A5130E75E2Q38702032-F8B45A32-1A7C-4500-B4F6-F84040C952B8Q38704349-04084EAE-A41D-4A12-8877-92D8409E433AQ38803541-4D87B609-7C0E-4AEE-98EA-BD1211F2A5B5Q39027049-F35E2BFE-CF93-4D24-B8E4-A6FC102789F1Q39318444-43D19A30-08C5-4C9B-A476-84449B26FA5FQ40061831-6E9B4E2C-A98B-4547-AE5B-1161DA615BADQ40063760-3F70ACE2-6992-4992-98DA-DD65CE1C6C3DQ40749296-A0B4C201-A639-4845-AA85-C6DA3F6DA008Q40866223-DFC653F3-5885-4F1B-B16E-8CAAF37DCFC2Q40928836-F87E32B5-CF10-45B2-8777-B4D9CE2FE521Q41440875-55AC0140-96AC-455D-B8D1-2AA590D086E8Q45325102-43B5FBE5-EAF6-4C63-B921-A23367D0A10FQ47108657-10D931CC-6DFA-479A-AA15-3423C905249DQ47120261-921D84DD-E79F-4D36-BD91-B696FFDA0B01Q47549249-2F433743-3A37-4808-B573-0C44248587EFQ49361412-02C7C8E6-C5FC-444D-9F8A-41905E196EA9Q52649839-4CF43F0C-28B1-4C72-AB54-C640424A86AFQ55293109-7CD65EE3-88F1-4ECE-AAB7-992C2D322412Q56379720-AFBBB309-1375-47AD-B5FB-1BD97D2AFE51Q58701856-720F4D3A-A7F4-4379-B0F5-9AC6E0A70342Q58748726-E3436951-83E1-4BC6-A720-2E4DE5591D91
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Immunity to RSV in Early-Life.
@ast
Immunity to RSV in Early-Life.
@en
Immunity to RSV in Early-Life.
@nl
type
label
Immunity to RSV in Early-Life.
@ast
Immunity to RSV in Early-Life.
@en
Immunity to RSV in Early-Life.
@nl
prefLabel
Immunity to RSV in Early-Life.
@ast
Immunity to RSV in Early-Life.
@en
Immunity to RSV in Early-Life.
@nl
P2860
P356
P1476
Immunity to RSV in Early-Life
@en
P2093
Agnes M Sagfors
Laura Lambert
P2860
P356
10.3389/FIMMU.2014.00466
P577
2014-09-29T00:00:00Z